Matches in Nanopublications for { ?s ?p "[In this study, a decrease in matrix metalloprotease-9 (MMP-9) but not of MMP-2 and the tissue inhibitors of MMP (TIMP-1 and TMP-2) was observed in the plasma of chronic hepatitis C patients at the end of the follow-up period after ribavirin plus interferon-alpha2b (PEG-IFN-alpha2b) treatment in sustained virologic responders but not in nonresponders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP549261.RAQzVrn78aQZsOQ3nuaDbNuAWx7i22m4lyVDfDzk-hDTQ130_assertion description "[In this study, a decrease in matrix metalloprotease-9 (MMP-9) but not of MMP-2 and the tissue inhibitors of MMP (TIMP-1 and TMP-2) was observed in the plasma of chronic hepatitis C patients at the end of the follow-up period after ribavirin plus interferon-alpha2b (PEG-IFN-alpha2b) treatment in sustained virologic responders but not in nonresponders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP549261.RAQzVrn78aQZsOQ3nuaDbNuAWx7i22m4lyVDfDzk-hDTQ130_provenance.
- NP467757.RAWXeSEI41ze53zHYg1DZNLLEOeP6-ivNf_xBM12ay9_A130_assertion description "[In this study, a decrease in matrix metalloprotease-9 (MMP-9) but not of MMP-2 and the tissue inhibitors of MMP (TIMP-1 and TMP-2) was observed in the plasma of chronic hepatitis C patients at the end of the follow-up period after ribavirin plus interferon-alpha2b (PEG-IFN-alpha2b) treatment in sustained virologic responders but not in nonresponders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP467757.RAWXeSEI41ze53zHYg1DZNLLEOeP6-ivNf_xBM12ay9_A130_provenance.
- NP811548.RAwgM-AtOc55vRCN-tmH1kN__mQGbdFMVd19rO__8Ibz4130_assertion description "[In this study, a decrease in matrix metalloprotease-9 (MMP-9) but not of MMP-2 and the tissue inhibitors of MMP (TIMP-1 and TMP-2) was observed in the plasma of chronic hepatitis C patients at the end of the follow-up period after ribavirin plus interferon-alpha2b (PEG-IFN-alpha2b) treatment in sustained virologic responders but not in nonresponders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP811548.RAwgM-AtOc55vRCN-tmH1kN__mQGbdFMVd19rO__8Ibz4130_provenance.